Hunan Sailong Pharmaceutical Co.,Ltd
As of 18 November 2026, for the company name Hunan Sailong Pharmaceutical Co.,Ltd as recorded, the chemical-drug catalogue lists 17 active records with this name as holder; 32 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
20 acceptance records as first applicant, grouped into 12 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Tranexamic Acid Injection 4 records · Latest accepted 2026/09/23
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601801 | Supplement | 2026/09/23 | Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized | CDE ↗ |
| CYHB2201800 | Supplement | 2022/09/30 | Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized | CDE ↗ |
| CYHB2150700 | Supplement | 2021/07/05 | Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
| CYHB2150179 | Supplement | 2021/03/27 | Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
Argatroban Injection 2 records · Latest accepted 2026/07/20
Supplement · 2
注射用右兰索拉唑 · No verified English name 2 records · Latest accepted 2025/04/08
Generic · 1Supplement · 1
Tedizolid Phosphate For Injection 1 records · Latest accepted 2024/11/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404060 | Generic | 2024/11/26 | Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
Pregabalin Capsules 2 records · Latest accepted 2024/03/20
Supplement · 1Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400404 | Supplement | 2024/03/20 | Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized | CDE ↗ |
| CYHS2200350 | Generic | 2022/02/21 | Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized | CDE ↗ |
Fosaprepitant Dimeglumine for Injection 2 records · Latest accepted 2023/12/22
Generic · 2
Esomeprazole Sodium for Injection 2 records · Latest accepted 2022/09/10
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201631 | Supplement | 2022/09/10 | Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized | CDE ↗ |
| CYHB2200053 | Supplement | 2022/01/11 | Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized | CDE ↗ |
Apixaban Tablets 1 records · Latest accepted 2022/03/22
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200472 | Generic | 2022/03/22 | Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized | CDE ↗ |
Tigecycline for Injection 1 records · Latest accepted 2021/06/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150697 | Supplement | 2021/06/25 | Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
Thymalfasin for Injection 1 records · Latest accepted 2021/03/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150173 | Supplement | 2021/03/25 | Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
门冬氨酸鸟氨酸注射液 · No verified English name 1 records · Latest accepted 2021/01/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2100070 | Supplement | 2021/01/11 | Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
注射用左旋泮托拉唑钠 · No verified English name 1 records · Latest accepted 2020/01/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS1900885 | Generic | 2020/01/08 | Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
Changes in the last 90 days
3 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 1 applicationNo longer listed under review: 1 applicationNotification delivery: 1 application
- 2026/11/18No longer listed under review
Argatroban Injection
CYHB2601376
Fact date: 2026/11/18 · Date added to this site: 2026/11/18
Accepted: 2026/07/20
no longer on the CDE under-review list as of the data cut-off; NMPA published notification delivery for this acceptance number on 2026/11/17; the notification contents are not public and the outcome remains unverified; this is a supplemental application, not counted as a new marketing approval · NMPA source · row 7
NMPA · Table row 7 ↗ View source ↗ - 2026/11/17Notification delivery
Argatroban Injection
CYHB2601376
Fact date: 2026/11/17 (Publication date) · Publication date: 2026/11/17 · Date added to this site: 2026/11/17
Notification delivered; the specific outcome remains to be checked.
View source · Table row 7 ↗ - 2026/09/23Accepted
Tranexamic Acid Injection
CYHB2601801
Fact date: 2026/09/23 · Date added to this site: 2026/10/22
View source ↗
Under review
2 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Tranexamic Acid Injection | CYHB2601801 | Supplement | 2026/09/23 | Hunan Sailong Pharmaceutical Co.,Ltd; Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized | CDE ↗ |
| 注射用左旋泮托拉唑钠 · No verified English name | CYHS1900885 | Generic | 2020/01/08 | Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
Catalogue holder records
17 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 注射用右兰索拉唑 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20265372 | 2026/07/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tedizolid Phosphate For Injection | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20264393 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pregabalin Capsules | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized | 国药准字H20247280 | 2024/11/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pregabalin Capsules | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized | 国药准字H20243261 | 2024/02/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Apixaban Tablets | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized | 国药准字H20234604 | 2023/12/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Argatroban Injection | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20227090 | 2022/07/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Thymalfasin for Injection | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20193385 | 2022/04/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tigecycline for Injection | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20193363 | 2022/04/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tranexamic Acid Injection | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20183507 | 2022/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tranexamic Acid Injection | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20227024 | 2022/03/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Parecoxib Sodium for Injection | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20227001 | 2022/01/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Parecoxib Sodium for Injection | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20193217 | 2022/01/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Milrinone Injection | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20217139 | 2021/12/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Milrinone Injection | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20143122 | 2021/12/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pantoprazole Sodium For Injection | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20123369 | 2021/08/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Omeprazole Sodium for Injection | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20173315 | 2021/05/14 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Esomeprazole Sodium for Injection | Hunan Sailong Pharmaceutical Co.,Ltd | Hunan Sailong Pharmaceutical Co.,Ltd | 国药准字H20203720 | 2020/12/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
32 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 克林霉素磷酸酯 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20250000203 | I | 2025/03/14 | CDE ↗ |
| 培美曲塞二钠 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20240001111 | A | 2026/05/28 | CDE ↗ |
| 硫酸艾沙康唑 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20240001110 | I | 2024/11/06 | CDE ↗ |
| 磷酸特地唑胺 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20240000924 | A | 2026/04/23 | CDE ↗ |
| 右兰索拉唑 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20240000786 | A | 2025/12/11 | CDE ↗ |
| 门冬氨酸镁 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20240000685 | A | 2025/11/26 | CDE ↗ |
| 门冬氨酸钾 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20240000684 | A | 2025/11/26 | CDE ↗ |
| 吡拉西坦 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20230000964 | A | 2025/01/21 | CDE ↗ |
| 尼可地尔 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20230000829 | A | 2024/12/11 | CDE ↗ |
| 伏立康唑 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20230000848 | A | 2025/02/19 | CDE ↗ |
| 法莫替丁 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20230000305 | A | 2024/12/31 | CDE ↗ |
| 奥美拉唑钠 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20230000255 | A | 2024/09/02 | CDE ↗ |
| 氟尿嘧啶 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20230000190 | A | 2024/09/30 | CDE ↗ |
| 托拉塞米 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20230000254 | A | 2024/09/02 | CDE ↗ |
| 盐酸艾司洛尔 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20230000197 | A | 2026/03/11 | CDE ↗ |
| 富马酸丙酚替诺福韦 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20220000689 | A | 2024/05/31 | CDE ↗ |
| 阿哌沙班 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20210001070 | A | 2023/12/13 | CDE ↗ |
| 利伐沙班 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20210001030 | A | 2023/05/30 | CDE ↗ |
| 普瑞巴林 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20210000955 | A | 2024/03/07 | CDE ↗ |
| 福沙匹坦双葡甲胺 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20210000425 | A | 2024/06/28 | CDE ↗ |
| 氨甲环酸 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20210000177 | A | 2026/05/08 | CDE ↗ |
| 赖氨匹林 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20190021313 | A | 2024/05/21 | CDE ↗ |
| 左旋泮托拉唑钠 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20190000894 | I | 2019/11/20 | CDE ↗ |
| 米力农 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20190007466 | A | — | CDE ↗ |
| 单唾液酸四己糖神经节苷脂钠 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20190006297 | A | — | CDE ↗ |
| 多立培南 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20170001690 | I | — | CDE ↗ |
| 右旋兰索拉唑 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20170001520 | I | — | CDE ↗ |
| 阿加曲班 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20170001241 | A | 2023/12/05 | CDE ↗ |
| 门冬氨酸鸟氨酸 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20170000711 | A | 2023/07/04 | CDE ↗ |
| 帕瑞昔布钠 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20170000607 | A | 2023/08/24 | CDE ↗ |
| 艾司奥美拉唑钠 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20170000550 | A | 2025/05/07 | CDE ↗ |
| 替加环素 · No verified English name | Hunan Sailong Pharmaceutical Co.,Ltd | Y20170000076 | A | 2024/06/25 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
10 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Isavuconazonium Sulfate for Injection | CYHS2500335 | Generic | 2025/01/17 | Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
| Nicorandil for Injection | CYHS2401411 | Generic | 2024/05/11 | Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
| Nicorandil for Injection | CYHS2401410 | Generic | 2024/05/11 | Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
| Nicorandil for Injection | CYHS2401409 | Generic | 2024/05/11 | Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
| Voriconazole for Injection | CYHS2303481 | Generic | 2023/12/15 | Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
| Torsemide Injection | CYHS2303262 | Generic | 2023/11/25 | Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
| Torsemide Injection | CYHS2303261 | Generic | 2023/11/25 | Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
| Famotidine Injection | CYHS2303140 | Generic | 2023/11/15 | Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
| Famotidine Injection | CYHS2303139 | Generic | 2023/11/15 | Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
| Esmolol Hydrochloride Injection | CYHS2301503 | Generic | 2023/06/02 | Hunan Sai Long Pharma (Changsha) Co., Ltd. romanized; Hunan Sailong Pharmaceutical Co.,Ltd | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.